Title Physician

Pembrolizumab and Pemetrexed for Progressive Chordoma

NCT ID : NCT06794645
Phase : 2
Location : Saint John's Cancer Institute
 Naveed Wagle, M.D.

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/​R PCNSL)

NCT ID : NCT03328078
Phase : 1/2
Location : Saint John's Cancer Institute
 Naveed Wagle, M.D.

A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM (RESTORE)

NCT ID : NCT03862430
Phase : 2
Location : Saint John's Cancer Institute
 Naveed Wagle, M.D.

A Randomized Controlled Phase 2 Study of the Ketogenic Diet Versus Standard Dietary Guidance for Patients With Newly Diagnosed Glioblastoma in Combination With Standard-of-care Treatment

NCT ID : 05708352
Protocol Number : IIT2022-06-HU-DIET2TREAT
Phase : 2
Location : Santa Monica, CA
 Naveed Wagle, M.D.

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma

NCT ID : 05561374
Protocol Number : OKN-007-OL
Phase : 1
Location : Saint John's Cancer Institute
 Naveed Wagle, M.D.